The global healthcare industry is witnessing rapid transformation as immunotherapy continues to redefine cancer treatment approaches. Anti-PD-1 antibodies have emerged as one of the most promising therapeutic innovations in oncology, helping improve patient outcomes across multiple cancer indications. Increasing adoption of precision medicine, rising cancer prevalence, and continuous...